Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center
发明人:
TSAI, Guochuan, Emil
申请号：
DK10733788
公开号：
DK2389187T3
申请日:
2010.01.19
申请国别(地区):
DK
年份:
2017
代理人:
摘要：
Methods and compositions are provided for treating neuropsychiatric disorders such as schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, and bipolar disorder. The methods entail administering to a patient diagnosed as having a neuropsychiatric disorder ( e . g ., schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia bipolar disorder, etc .) or as at risk for a neuropsychiatric disorder a benzoic acid, benzoic acid salt, and/or benzoic acid derivative, and/or a sorbic acid, sorbic acid salt, and/or sorbic acid derivative, in combination with a neuropharmacological agent ( e . g ., an antipsychotic, an antidepressant, medications for attention deficit and hyperactivity disorder, cognitive impairment, or dementia, etc. ) where the benzoic acid, benzoic acid salt, or benzoic acid derivative, and/or a sorbic acid, sorbic acid salt, and/or sorbic acid derivative, is in an amount sufficient to increase the efficacy of the neuropharmacological agent.
